You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 295 No. 2, January 11, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Pacemakers/ Defibrillators
 •Cardiovascular System
 •Quality of Care
 •Quality of Care, Other
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Malfunctions of Implantable Cardioverter Defibrillators

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In his Commentary on the implications of recent implantable cardioverter defibrillator malfunctions for safety issues involving medical devices,1 Dr Maisel inferred that St Jude Medical's method of estimating failure rates was flawed and would underestimate the true incidence of device failures. He based this statement on an editorial comment2 referencing the device manufacturer's field advisory in 2000 on Trilogy pacemakers.

The Commentary stated that "a microprocessor anomaly was observed in 20 out of 144 000 Trilogy pacemakers." In the course of the standard evaluation of devices that were returned to St Jude Medical, an anomaly with the microprocessor-integrated circuit was detected. Potential manifestations included interrogation/programming difficulties, unexpected rate variation, abnormally high battery current reading, or a mode change, and the theoretically more serious problem of an inappropriate mode change to a single-chamber atrial pacing mode. Out of the total number, the mode change behavior had been identified in . . . [Full Text of this Article]

Paul A. Levine, MD
plevine@sjm.com

Gabriel Kohanyi
St Jude Medical CRMD
Sylmar, Calif



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Malfunctions of Implantable Cardioverter Defibrillators—Reply
William H. Maisel
JAMA. 2006;295(2):161-162.
EXTRACT | FULL TEXT  

Safety Issues Involving Medical Devices: Implications of Recent Implantable Cardioverter-Defibrillator Malfunctions
William H. Maisel
JAMA. 2005;294(8):955-958.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Semper Fidelis -- Consumer Protection for Patients with Implanted Medical Devices
Maisel
NEJM 2008;358:985-987.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.